A case of giant esophageal cancer undergoing surgical resection after chemotherapy combined with immunotherapy

Asian J Surg. 2023 Jun;46(6):2412-2413. doi: 10.1016/j.asjsur.2022.12.037. Epub 2023 Jan 7.

Authors

Ya-Qing Han¹, Kai-Hong Han¹, Guang-Jie Liu¹, Qing-Yi Liu²

Affiliations

¹ Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
² Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Electronic address: zhongmeijian-lqy@163.com.

PMID: 36621422
DOI: 10.1016/j.asjsur.2022.12.037

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Combined Modality Therapy
Esophageal Neoplasms* / surgery
Humans
Immunotherapy
Neoadjuvant Therapy